Payer
Swing Therapeutics CEO Mike Rosenbluth discusses the company's fibromyalgia management tool and what's necessary to make digital therapeutics mainstream.
HIMSS22
Bluestream Health president Brian Yarnell talks about how the company assists health systems in creating virtual health front doors to improve equity for those in underserved populations.
SteadyMD announced a $25 million Series B raise in March 2021.
Of the 224 companies analyzed, 98 received a clinical robustness score of zero.
HIMSS22
Andrew Sorenson, Castell's chief analytics officer, discusses how healthcare providers can go beyond obvious uses in implementing value-based care.
HIMSS22
Michael Green, president and CEO of Canada Health Infoway, discusses how telehealth adoption following the pandemic has helped kids find and use mental healthcare.
HIMSS22
Facilities being created now must incorporate the next 10 years of tech, says Samantha Field, public health registrar at NHS.
HIMSS22
Diane Swonk, Grant Thornton's chief economist, discusses the pandemic-fueled burnout's impact on healthcare organizations, and how employers can help support mental and physical health.
Brigham Hyde, Atropos Health's cofounder, board chair and CEO discusses getting actionable insights to patients by employing updated research-grade data.